Showing results (181-190 of 345) with videos related to
Sort By:
Pageof 35
Journal of Pediatric Surgery|March 29, 2006
Bilateral Wilms' tumors with progressive or nonresponsive diseaseRobert C Shamberger, Gerald M Haase, Pedram Argani, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2020
NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterationsYu-Chien Kao, Yun-Shao Sung, Pedram Argani, et al.Human Pathology|April 26, 2015
Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?Nathaniel E Smith, Jonathan I Epstein, Anil V Parwani, et al.Oncogene|April 4, 2003
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breastScott L Kominsky, Pedram Argani, Dorian Korz, et al.BMC Cancer|July 1, 2006
Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast diseaseLisa Gallicchio, Sonja I Berndt, Meghan A McSorley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of VaterDonna E Hansel, Anirban Maitra, John W Lin, et al.Annals of Surgical Oncology|October 17, 2008
Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteriaAnna M Voltura, Theodore N Tsangaris, Gedge D Rosson, et al.The American Journal of Surgical Pathology|August 16, 2012
Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumPedram Argani, Raluca Yonescu, Laura Morsberger, et al.Cancer Research|February 7, 2007
TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibitionMasumi Tsuda, Ian J Davis, Pedram Argani, et al.Journal of Clinical Pathology|July 6, 2014
NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomasRebecca J Asch-Kendrick, Mark A Samols, Mohammed T Lilo, et al.Pageof 35